According to Zhitong Finance App, Kangtai Biotech (300601.SZ) announced that Mr. Miao Xiang, the director and president of the company, holds 1,884,700 shares of the company (accounting for 0.17% of the company's total share capital) and plans to reduce the company's holdings by no more than 471,000 shares (i.e. no more than 0.04% of the company's total share capital ratio) within three months after 15 trading days from the date of disclosure of the announcement (except for the time when laws, regulations and regulatory documents stipulate that holdings cannot be reduced).

According to Zhitong Finance App, Kangtai Biotech (300601.SZ) announced that Mr. Miao Xiang, the director and president of the company, holds 1,884,700 shares of the company (accounting for 0.17% of the company's total share capital) and plans to reduce the company's holdings by no more than 471,000 shares (i.e. no more than 0.04% of the company's total share capital ratio) within three months after 15 trading days from the date of disclosure of the announcement (except for the time when laws, regulations and regulatory documents stipulate that holdings cannot be reduced).